维普中文期刊产品整合服务
29篇 您的检索式:作者名="SLINGLUFF CL"
    题名 作者 年代 出处 被引量
1Phase I trial of a mel-anoma vaccine with gp100(280-288)peptide and tetanus helperpeptide in adjuvant:immunologic and clinical outcomes显示文摘Slingluff CL Jr Yamshchikov G Neese P 2001ClinCancer Res2001,7,10:1
2Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients 显示文摘 Vollmer HF Seigler HF 1990Surgery1990,107,1:1
3Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients 显示文摘Slingluff CL Jr Vollmer HF Seigler HF 1990Surgery1990,107,1:1
4Helper T-cell responses and elinieal activity of a melanoma vaccine with multiple peptides from MAGE and melanoeytie differentiation antigens 显示文摘Slingluff CL Jr Petroni GR Olson W 2008J Clin Oncol2008,26,30:1
5Clinical activity and safety of combination therapy with temsirolimus and bevaci- zumab for advanced melanoma: a phase II trial ( CTEP 7190/ Me147) 显示文摘Slingluff CL Jr Petroni GR Molhoek KR 2013Clin Cancer Res2013,19,13:1
6Anorectal melanoma:clinical characteristics and results of surgical management in twenty-four patients显示文摘Slingluff CL Jr Vollmer RT Seigler HF 1990Surgery1990,107,1:1
7Immunologic and clinical outcomes of a randomized phase II trial of two multi peptide vaccines for melanoma in the adjuvant setting显示文摘Slingluff CL Ir Petroni GR Chianese Bullock KA 2007Clin Cancer Res2007,13,21:1
8Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule显示文摘Slingluff CL Jr Petroni GR Yamshchikov GV 2004J Clin Oncol2004,22,22:1
9Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients 显示文摘Slingluff CL Jr Vollmer RT Seigler HF 1990Surgery1990,107,1:1
10Effect of granulocyte/macrophage colony -stimulating factor on circulating CD8^+ and CD4^+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial显示文摘Slingluff CL Jr Petroni GR Olson WC 2009Clin Cancer Res2009,15,22:1
11Clinical and immunologic results of a randomized phase Ⅱ trial of vaccination using four melanoma peptides either administered in granulocyte macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells显示文摘 Petroni GR Yamshchikov GV 2003J Clin Oncol2003,21,21:1
12Tumor antigens and tumor vaccines:peptides as immunogens 显示文摘Slingluff CL 1996Semin Surg Oncol1996,12,:1
13CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease显示文摘Mullins IM Slingluff CL Lee JK 2004Cancer Res2004,64,21:1
14Clinical and immunologic resuits of a randomized phase Ⅱ trial of vaccination using four melanoma peptides either administered in granuloyte- macrophage colony- stimulating factor in adjuvant or palsed on dendritic cells 显示文摘Slingluff CL Jr Petroni GR Yamshchikov GV 2003J Clin Oncol2003,21,21:1
15Helper T-cell respon?ses and clinical activity of a melanoma vaccine with multiple pep?tides from MAGE and melanocytic differentiation antigens 显示文摘Slingluff CL Jr Petroni GR Olson W 2008J Clin Oncol2008,26,49:1
16Phase I trial of a melanoma vaccine with GP100 (280- 288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes显示文摘 Yamshchikov Jr G Neese P 2001Clin Cancer Res2001,7,:1
17Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin显示文摘MOLHOEK KR BRAUTIGAN DL SLINGLUFF CL Jr 2005J Transl Med2005,28,3:1
18Anorectal melanoma:clinical characteristics and results of surgical management in twenty-four patients显示文摘 Vollmer RT Seigler HF 1990Surgery1990,107,1:1
19Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients 显示文摘Slingluff CL Vollmer RT Seigler HF 1990Surgery1990,107,:1
20Anorectal melanoma: Clinical characteristics and results of surgical management in twenty-four patients显示文摘SLINGLUFF CL JR VOLLMER RT SEIGLER HF 1990Surgery1990,107,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费